382 related articles for article (PubMed ID: 31522574)
41. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
42. Rationale and clinical status of local hyperthermia, radiation, and chemotherapy in locally advanced malignancies.
Feyerabend T; Steeves R; Wiedemann GJ; Richter E; Robins HI
Anticancer Res; 1997; 17(4B):2895-7. PubMed ID: 9329557
[TBL] [Abstract][Full Text] [Related]
43. Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer.
Hervault A; Thanh NT
Nanoscale; 2014 Oct; 6(20):11553-73. PubMed ID: 25212238
[TBL] [Abstract][Full Text] [Related]
44. Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience.
Colombo R; Salonia A; Da Pozzo LF; Naspro R; Freschi M; Paroni R; Pavone-Macaluso M; Rigatti P
Crit Rev Oncol Hematol; 2003 Aug; 47(2):127-39. PubMed ID: 12900006
[TBL] [Abstract][Full Text] [Related]
45. [Clinical evaluation of combination hyperthermia and radiation therapy for superficial tumors].
Matsuda T; Tanaka Y; Takeshita N
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1353-9. PubMed ID: 3729454
[TBL] [Abstract][Full Text] [Related]
46. Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial.
Kapp DS; Petersen IA; Cox RS; Hahn GM; Fessenden P; Prionas SD; Lee ER; Meyer JL; Samulski TV; Bagshaw MA
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1481-95. PubMed ID: 2262371
[TBL] [Abstract][Full Text] [Related]
47. Targeted near infrared hyperthermia combined with immune stimulation for optimized therapeutic efficacy in thyroid cancer treatment.
Zhou L; Zhang M; Fu Q; Li J; Sun H
Oncotarget; 2016 Feb; 7(6):6878-90. PubMed ID: 26769848
[TBL] [Abstract][Full Text] [Related]
48. Injectable Hydrogels as Unique Platforms for Local Chemotherapeutics-Based Combination Antitumor Therapy.
Yu S; He C; Chen X
Macromol Biosci; 2018 Dec; 18(12):e1800240. PubMed ID: 30303620
[TBL] [Abstract][Full Text] [Related]
49. Adapting conventional cancer treatment for immunotherapy.
Qiao J; Liu Z; Fu YX
J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
[TBL] [Abstract][Full Text] [Related]
50. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
Shahabi V; Postow MA; Tuck D; Wolchok JD
Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of combination immunotherapy for malignant solid tumors: A systematic review and meta-analysis.
Wei Y; Du Q; Jiang X; Li L; Li T; Li M; Fan X; Li Y; Kariminia S; Li Q
Crit Rev Oncol Hematol; 2019 Jun; 138():178-189. PubMed ID: 31092375
[TBL] [Abstract][Full Text] [Related]
52. Narrow line between benefit and harm: Additivity of hyperthermia to cisplatin cytotoxicity in different gastrointestinal cancer cells.
Cesna V; Sukovas A; Jasukaitiene A; Naginiene R; Barauskas G; Dambrauskas Z; Paskauskas S; Gulbinas A
World J Gastroenterol; 2018 Mar; 24(10):1072-1083. PubMed ID: 29563752
[TBL] [Abstract][Full Text] [Related]
53. Hyperthermia and immunotherapy: clinical opportunities.
Hurwitz MD
Int J Hyperthermia; 2019 Nov; 36(sup1):4-9. PubMed ID: 31795827
[TBL] [Abstract][Full Text] [Related]
54. [Addition of hyperthermia. Heat potentiates cancer therapy].
Hegewisch-Becker S; Hossfeld DK
MMW Fortschr Med; 2001 Jun; 143(25):28-32. PubMed ID: 11468993
[TBL] [Abstract][Full Text] [Related]
55. Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience.
Lloret M; García-Cabrera L; Hernandez A; Santana N; López-Molina L; Lara PC
Clin Transl Oncol; 2019 Dec; 21(12):1771-1775. PubMed ID: 31102061
[TBL] [Abstract][Full Text] [Related]
56. A review of systemic hyperthermia.
Bull JM
Front Radiat Ther Oncol; 1984; 18():171-6. PubMed ID: 6423453
[No Abstract] [Full Text] [Related]
57. Clinical hyperthermia combined with drugs and radiation. A phase I/II study.
Dahl O; Mella O; Mehus A; Liavaag PG
Strahlenther Onkol; 1987 Jul; 163(7):446-8. PubMed ID: 3616903
[No Abstract] [Full Text] [Related]
58. Radiotherapy in conjunction with superficial and intracavitary hyperthermia for the treatment of solid tumors: survival and thermal parameters.
Triantopoulou S; Efstathopoulos E; Platoni K; Uzunoglou N; Kelekis N; Kouloulias V
Clin Transl Oncol; 2013 Feb; 15(2):95-105. PubMed ID: 23180345
[TBL] [Abstract][Full Text] [Related]
59. Referee: hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer.
Dahl O; Mella O
Int J Hyperthermia; 2002; 18(1):25-30. PubMed ID: 11820464
[TBL] [Abstract][Full Text] [Related]
60. Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
Apetoh L; Ladoire S; Coukos G; Ghiringhelli F
Ann Oncol; 2015 Sep; 26(9):1813-1823. PubMed ID: 25922066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
